In early August, inspectors from the Food and Drug Administration (FDA) visited Central Admixture Pharmacy Services in Miramar and found multiple potential violations of new drug-making safety ...
UPPER MACUNGIE TOWNSHIP – Federal authorities have put a specialty-pharmacy company affiliated with Bethlehem’s B. Braun on notice about “serious deficiencies” in its practices regarding sterilized ...
In Nexus Pharmaceuticals, Inc. v. Central Admixture Pharmacy Services, Inc., 48 F.4th 1040, 1041 (9th Cir. 2022), the Ninth Circuit recently held that the implied preemption doctrine barred state law ...
Sept. 19, 2005 — The U.S. Food and Drug Administration (FDA) and Central Admixture Pharmacy Services Inc. (CAPS) have notified healthcare professionals via letter concerning the recall of all ...
Medical device manufacturer B. Braunon Thursday celebrated the opening of a new pharmaceutical facility in Fogelsville. The 32,000-square-foot “sterile compounding” pharmacy, which makes intravenous ...
At more than 249,000 sq ft, this high-tech facility for Central Admixture Pharmacy Services produces non-patient-specific compounded sterile preparations, mostly for clinical applications. The ...
Central Admixture Pharmacy Services Polsinelli PC SECOND QUARTER REPORT $50,000 Central Admixture Pharmacy Services Polsinelli PC THIRD QUARTER REPORT $50,000 Central Admixture Pharmacy Services ...
There are no commercially available solutions of compounded cardioplegia, a drug used to temporarily stop the heart during surgery, after the FDA cited the nation’s only pharmacy that compounded the ...
Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company, announced today the launch of its newest service for the admixture and delivery of Hibernation Therapeutics' patented Adenocaine™ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback